448 related articles for article (PubMed ID: 21733326)
21. Cimicifuga racemosa impairs fatty acid β-oxidation and induces oxidative stress in livers of ovariectomized rats with renovascular hypertension.
Campos LB; Gilglioni EH; Garcia RF; Brito Mdo N; Natali MR; Ishii-Iwamoto EL; Salgueiro-Pagadigorria CL
Free Radic Biol Med; 2012 Aug; 53(4):680-9. PubMed ID: 22684021
[TBL] [Abstract][Full Text] [Related]
22. Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats.
Gómez-Zorita S; Fernández-Quintela A; Lasa A; Hijona E; Bujanda L; Portillo MP
Nutrition; 2013; 29(11-12):1374-80. PubMed ID: 24012391
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
Rocha KK; Souza GA; Ebaid GX; Seiva FR; Cataneo AC; Novelli EL
Food Chem Toxicol; 2009 Jun; 47(6):1362-7. PubMed ID: 19298841
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
Palsamy P; Sivakumar S; Subramanian S
Chem Biol Interact; 2010 Jul; 186(2):200-10. PubMed ID: 20307516
[TBL] [Abstract][Full Text] [Related]
25. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
[TBL] [Abstract][Full Text] [Related]
26. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine.
Bonfleur ML; Borck PC; Ribeiro RA; Caetano LC; Soares GM; Carneiro EM; Balbo SL
Life Sci; 2015 Aug; 135():15-21. PubMed ID: 26092479
[TBL] [Abstract][Full Text] [Related]
27. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
28. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
29. Effect of starvation on hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and acetyl-CoA carboxylase mRNA levels in rats.
Ryu MH; Daily JW; Cha YS
Nutrition; 2005 Apr; 21(4):537-42. PubMed ID: 15811777
[TBL] [Abstract][Full Text] [Related]
30. Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice.
Naowaboot J; Wannasiri S; Pannangpetch P
J Physiol Biochem; 2016 Jun; 72(2):269-80. PubMed ID: 26976296
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
32. Liver delipidating effect of a combination of resveratrol and quercetin in rats fed an obesogenic diet.
Arias N; Macarulla MT; Aguirre L; Miranda J; Portillo MP
J Physiol Biochem; 2015 Sep; 71(3):569-76. PubMed ID: 25827944
[TBL] [Abstract][Full Text] [Related]
33. Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats.
Aguirre L; Palacios-Ortega S; Fernández-Quintela A; Hijona E; Bujanda L; Portillo MP
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035507
[TBL] [Abstract][Full Text] [Related]
34. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
35. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
36. Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
Louis XL; Thandapilly SJ; MohanKumar SK; Yu L; Taylor CG; Zahradka P; Netticadan T
J Nutr Biochem; 2012 Sep; 23(9):1163-9. PubMed ID: 22137269
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.
Kasdallah-Grissa A; Mornagui B; Aouani E; Hammami M; El May M; Gharbi N; Kamoun A; El-Fazaâ S
Life Sci; 2007 Feb; 80(11):1033-9. PubMed ID: 17258234
[TBL] [Abstract][Full Text] [Related]
38. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
39. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
Zheng H; Li S; Ma L; Cheng L; Deng C; Chen Z; Xie C; Xiang M; Jiang W; Chen L
Eur J Pharmacol; 2011 Jun; 659(2-3):244-51. PubMed ID: 21463618
[TBL] [Abstract][Full Text] [Related]
40. Selenium significantly inhibits adipocyte hypertrophy and abdominal fat accumulation in OLETF rats via induction of fatty acid β-oxidation.
Kim JE; Choi SI; Lee HR; Hwang IS; Lee YJ; An BS; Lee SH; Kim HJ; Kang BC; Hwang DY
Biol Trace Elem Res; 2012 Dec; 150(1-3):360-70. PubMed ID: 23076603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
